The SARS-CoV-2 pandemic caused millions of deaths around the world. This dramatic balance requires governments, international organizations, vaccine manufacturers, and the scientific community itself to take stock of what has been done and what could have been done better. In this sense, the tremendous inequity in access to vaccines, the main tool to deal with the pandemic, deserves deep reflection and a set of actions to be carried out by low- and middle-income countries. Among them, the construction of a joint effort to produce their own vaccines and the reconsideration of the bases that govern the intellectual property rights of vaccines and medicines, which harmed equitable access to health, with the consequent loss of many lives that could have been saved.

SARS-CoV-2 大流行导致全球数百万人死亡。这种巨大的平衡要求各国政府、国际组织、疫苗制造商和科学界本身评估已经做了什么以及可以做得更好。从这个意义上说，作为应对疫情的主要工具，疫苗的获取存在巨大的不平等，值得中低收入国家深刻反思并采取一系列行动。其中，建立生产自己疫苗的共同努力以及重新考虑管理疫苗和药品知识产权的基础，这损害了公平获得健康的机会，从而导致许多本可以挽救的生命丧失。